Tuesday, November 10, 2026
AnalystEvercore ISI
Evercore ISI kept its Outperform rating on TG Therapeutics (TGTX) with a price target of $71.
Tuesday, September 1, 2026
AnalystHC Wainwright & Co.
HC Wainwright & Co. kept its Buy rating on TG Therapeutics (TGTX).
Frequently asked questions
What is the latest news on TGTX?
Nov 10, 2026: Evercore ISI kept its Outperform rating on TG Therapeutics (TGTX) with a price target of $71. (Evercore ISI) · Sep 1, 2026: HC Wainwright & Co. kept its Buy rating on TG Therapeutics (TGTX). (HC Wainwright & Co.)
What are analysts saying about TGTX?
Nov 10, 2026: Evercore ISI kept its Outperform rating on TG Therapeutics (TGTX) with a price target of $71. · Sep 1, 2026: HC Wainwright & Co. kept its Buy rating on TG Therapeutics (TGTX).
Get TGTX news as it happens
Every headline, SEC filing and analyst action for TGTX on your live chart, with important news marked and alerts when it matters.
Try SEPT Free